{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:25:31Z","timestamp":1776471931779,"version":"3.51.2"},"reference-count":103,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.4065\/74.12.1266","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:16:10Z","timestamp":1232759770000},"page":"1266-1283","source":"Crossref","is-referenced-by-count":25,"title":["Antiviral Agents for Non-Human Immunodeficiency Virus Infections"],"prefix":"10.4065","volume":"74","author":[{"given":"Michael R.","family":"Keating","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4065\/74.12.1266_bib1","first-page":"782","article-title":"Acyclovir: a decade later [published errata appear in N Engl J Med 1993;328:671) 1997;337:1703]","volume":"327","author":"Whltley","year":"1992","journal-title":"N EnglJMed"},{"key":"10.4065\/74.12.1266_bib2","doi-asserted-by":"crossref","first-page":"11447","DOI":"10.1016\/S0021-9258(19)68420-6","article-title":"Inhibition of purified human and herpes simplex virus-induced DNA poly-merases by 9(2-rtydroxyeltio>;yniethyl)-guanine triphosphate: effects on primer-template function","volume":"256","author":"Derse","year":"1981","journal-title":"J Biol Chem"},{"key":"10.4065\/74.12.1266_bib3","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1016\/0006-2952(81)90495-0","article-title":"Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities","volume":"30","author":"Kaliar","year":"1981","journal-title":"Bioctiem Pharmacol"},{"key":"10.4065\/74.12.1266_bib4","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1073\/pnas.80.13.4139","article-title":"9-{[2-Hydroxy-l-(hydroxymethyl)]ethoxy m-rnethyt}guanine: a selective inhibitor of herpes group virus replication","volume":"80","author":"Field","year":"1983","journal-title":"Proc Natl head Sci USA"},{"key":"10.4065\/74.12.1266_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/AAC.25.2.191","article-title":"Inhibition of cellular ct DNA polymerase and herpes simplex virus-induced DNA polymerases by the tri phosphate of BW759U","volume":"25","author":"Clair","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.12.1266_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/106002809703100211","article-title":"Valacyelovir","volume":"31","author":"Acosta","year":"1997","journal-title":"Ann Pnarmacother"},{"key":"10.4065\/74.12.1266_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0166-3542(95)00941-8","article-title":"Famciclovir: review of clinical efficacy and safety","volume":"29","author":"Clrelli","year":"1996","journal-title":"Antiviral Res"},{"key":"10.4065\/74.12.1266_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199631010-00001","article-title":"The clinical pharmacokinetics of famciclovir","volume":"31","author":"Gill","year":"1996","journal-title":"Ciin Pharmacokinet"},{"key":"10.4065\/74.12.1266_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003088-199936010-00004","article-title":"Clinical pharmacoKinetics of lamivudine","volume":"36","author":"Johnson","year":"1999","journal-title":"Ciin Pharmacokmet"},{"key":"10.4065\/74.12.1266_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(85)80002-4","article-title":"Basic biochemical and pharmacological aspects of antiviral agents","volume":"1","author":"PrusoH","year":"1985","journal-title":"Antiviral Res Suppl"},{"key":"10.4065\/74.12.1266_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1128\/AAC.30.2.201","article-title":"Biochemistry and clinical applications of ribavirin","volume":"30","author":"Gilbert","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.12.1266_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0168-1702(92)90056-F","article-title":"Regulation of pH by the M2 protein of influenza A viruses","volume":"22","author":"Clamper","year":"1992","journal-title":"Virus Res"},{"key":"10.4065\/74.12.1266_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-1-4615-4743-3_6","article-title":"Update on influenza and rhinovirus infections","volume":"458","author":"Hayden","year":"1999","journal-title":"Adv Sup Med Biol"},{"issue":"Suppl","key":"10.4065\/74.12.1266_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0002-9343(82)90100-0","article-title":"Treatment oicytomegalovirus pneumonia with high-dose acyclovir","volume":"73","author":"Wade","year":"1982","journal-title":"Am J Med"},{"key":"10.4065\/74.12.1266_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/infdis\/151.2.362","article-title":"Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster","volume":"151","author":"Bean","year":"1985","journal-title":"J Infect Dis"},{"key":"10.4065\/74.12.1266_bib16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(82)90658-4","article-title":"Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes","volume":"2","author":"Nilsen","year":"1982","journal-title":"Lancet"},{"key":"10.4065\/74.12.1266_bib17","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1001\/jama.1984.03340400031020","article-title":"Treatment of recurrent genital herpes simplex infections with oral acyclovir: a controlled trial","volume":"251","author":"Relchman","year":"1984","journal-title":"JAMA"},{"key":"10.4065\/74.12.1266_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/150.1.1","article-title":"A collaborative study of patient-initiated treatment of recurrent genital herpes with topical acyclovir or placebo","volume":"150","author":"Luby","year":"1984","journal-title":"J Infect Dis"},{"key":"10.4065\/74.12.1266_bib19","doi-asserted-by":"crossref","first-page":"914","DOI":"10.7326\/0003-4819-98-6-914","article-title":"Intravenous acyclovir for the treatment of primary genital herpes","volume":"98","author":"Corey","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.12.1266_bib20","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1001\/jama.1988.03410150075033","article-title":"Acyclovir suppression of frequently recurring genital herpes: efficacy and diminishing need during successive years of treatment","volume":"260","author":"Straus","year":"1988","journal-title":"JAMA"},{"key":"10.4065\/74.12.1266_bib21","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jama.1988.03720070051034","article-title":"Relapse of herpes simple encephalitis after conventional acyclovir therapy","volume":"259","author":"VanLandtngham","year":"1988","journal-title":"JAMA"},{"key":"10.4065\/74.12.1266_bib22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJM199102143240703","article-title":"A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection","volume":"324","author":"Whltley","year":"1991","journal-title":"fV Engl J Med"},{"key":"10.4065\/74.12.1266_bib23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1542\/peds.66.4.495","article-title":"Vidarabine therapy of neonatal herpes simplex virus infection","volume":"66","author":"Whitley","year":"1980","journal-title":"Pediatrics"},{"key":"10.4065\/74.12.1266_bib24","first-page":"361367","article-title":"Acyclovir prophylaxis for herpes simplex virus infection","volume":"31","author":"Gold","year":"1987","journal-title":"Antimicrob Agents Chemotner"},{"key":"10.4065\/74.12.1266_bib25","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM198306163082404","article-title":"Acyclovir halts progression of herpes zoster in immunocompromised patients","volume":"308","author":"Balfour","year":"1983","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1266_bib26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-3476(84)80611-3","article-title":"Intravenous acyclovir therapy for varicella in immunocompromised children","volume":"104","author":"Balfour","year":"1984","journal-title":"J Peoiatr"},{"issue":"Suppl 2A","key":"10.4065\/74.12.1266_bib27","first-page":"90","article-title":"Reduction of the ocular complications of herpes zoster ophthalmicus by oral acyclovir","volume":"85","author":"Cobo","year":"1988","journal-title":"Am J Med"},{"issue":"Suppl 2A","key":"10.4065\/74.12.1266_bib28","first-page":"84","article-title":"Therapy of herpes zoster with oral acyclovir","volume":"85","author":"Huff","year":"1988","journal-title":"Am J Med"},{"key":"10.4065\/74.12.1266_bib29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/clinids\/22.2.341","article-title":"Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials","volume":"22","author":"Wood","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.12.1266_bib30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-3476(05)81618-X","article-title":"Acyclovir treatment of varicella in otherwise healthy children","volume":"116","author":"Balfour","year":"1990","journal-title":"J Pediatr"},{"key":"10.4065\/74.12.1266_bib31","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7326\/0003-4819-117-5-358","article-title":"Oldfleld EC III. Treatment of adult varicella with oral acyclovir: a randomized. placebo-controlled trial","volume":"117","author":"Wallace","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.12.1266_bib32","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/clinids\/12.5.788","article-title":"Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults: retrospective controlled study and review","volume":"12","author":"Haake","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.4065\/74.12.1266_bib33","doi-asserted-by":"crossref","first-page":"922","DOI":"10.7326\/0003-4819-130-11-199906010-00017","article-title":"Recent advances in varicella-zoster virus infection","volume":"130","author":"Cohen","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.12.1266_bib34","doi-asserted-by":"crossref","first-page":"823","DOI":"10.7326\/0003-4819-100-6-823","article-title":"Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation","volume":"100","author":"Wade","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.12.1266_bib35","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1001\/jama.1985.03360240047032","article-title":"Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir","volume":"254","author":"Seals","year":"1985","journal-title":"JAMA"},{"key":"10.4065\/74.12.1266_bib36","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jama.1988.03720030044031","article-title":"Regression of oral hairy leukoplakia after orally administered acyclovir therapy","volume":"259","author":"Resnick","year":"1988","journal-title":"JAMA"},{"key":"10.4065\/74.12.1266_bib37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/infdis\/153.2.283","article-title":"Effect of acyclovir on infectious mononucleo-sis: a double-Wind, placebo-controlled study","volume":"153","author":"Andersson","year":"1986","journal-title":"J Infect Dis"},{"key":"10.4065\/74.12.1266_bib38","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1056\/NEJM198812293192602","article-title":"Acyclovir treatment of the chronic fatigue syndrome: lack of efficacy in a placebo-controlled trial","volume":"319","author":"Straus","year":"1988","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1266_bib39","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1128\/AAC.39.7.1546","article-title":"Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults","volume":"39","author":"Beutner","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.12.1266_bib40","first-page":"1729","article-title":"A large-scale, placebo-controlled. dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis","volume":"156","author":"Spruance","year":"1996","journal-title":"Arch fn\u00edem Med"},{"key":"10.4065\/74.12.1266_bib41","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1086\/515385","article-title":"[International Valaciclovir HSV Study Group). Valaciclovir for the suppression of recurrent genital herpes simple virus infection: a large-scale dose range-finding study","volume":"178","author":"Reitano","year":"1998","journal-title":"J Infect Dis"},{"key":"10.4065\/74.12.1266_bib42","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM199905133401903","article-title":"Valacyclovir for the prevention of cytomegatovirus disease after renal transplantation","volume":"340","author":"Lowance","year":"1999","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1266_bib43","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/S0021-9258(17)43446-6","article-title":"Interaction of herpes simplex virus induced DNA polymerase with 9-(1,3-dihydroxy-2-propoxymethyl)-guanine triphosphate","volume":"259","author":"Frank","year":"1984","journal-title":"J Biol Chem"},{"key":"10.4065\/74.12.1266_bib44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-113-2-111","article-title":"Toxicity of combined ganciclovir and zidowdine for cytomegalovirus disease associated with AIDS: an AIDS clinical trials group study","volume":"113","author":"Hochster","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.12.1266_bib45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00003495-199856010-00012","article-title":"Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients","volume":"56","author":"Noble","year":"1998","journal-title":"Drugs"},{"key":"10.4065\/74.12.1266_bib46","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/infdis\/168.3.557","article-title":"A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS","volume":"168","author":"Spector","year":"1993","journal-title":"J Infect Dis"},{"key":"10.4065\/74.12.1266_bib47","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJM199509073331002","article-title":"Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS","volume":"333","author":"Drew","year":"1995","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1266_bib48","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM199204303261803","article-title":"A controlled trial of ganciclovir to prevent cytomegatovirus disease after heart transplantation","volume":"326","author":"Merlgan","year":"1992","journal-title":"fV Engl J Med"},{"key":"10.4065\/74.12.1266_bib49","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJM199112053252303","article-title":"Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation","volume":"325","author":"Goodruh","year":"1991","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1266_bib50","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7326\/0003-4819-118-3-199302010-00003","article-title":"Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant","volume":"118","author":"Goodrlcb","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.12.1266_bib51","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(97)05535-9","article-title":"Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients [published erratum appears in Lancet 1998:351:454]","volume":"350","author":"Gane","year":"1997","journal-title":"Lancet"},{"key":"10.4065\/74.12.1266_bib52","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/0003-4819-109-10-777","article-title":"Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin","volume":"109","author":"Emanuel","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.12.1266_bib53","doi-asserted-by":"crossref","first-page":"783","DOI":"10.7326\/0003-4819-109-10-783","article-title":"Treat ment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants","volume":"109","author":"Reed","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.12.1266_bib54","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jac\/37.2.303","article-title":"Activity of penciclovir in antiviral assays against herpes simplex virus","volume":"37","author":"Bacon","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.4065\/74.12.1266_bib55","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1001\/jama.1997.03540410052030","article-title":"Penciclovir cream for the treatment of herpes simplex labialis: a randomized, multicenter, double-blind, placebo-controlled trial","volume":"277","author":"Spruance","year":"1997","journal-title":"JAMA"},{"key":"10.4065\/74.12.1266_bib56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jama.1996.03540010046029","article-title":"Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes: a randomized, double-blind multicenter trial","volume":"276","author":"Sacks","year":"1996","journal-title":"JAMA"},{"key":"10.4065\/74.12.1266_bib57","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jama.280.10.887","article-title":"Oral famciclovir for the suppression of recurrent genital herpes: a ran domized controlled trial","volume":"280","author":"Dlaz-Mltoma","year":"1998","journal-title":"JAMA"},{"key":"10.4065\/74.12.1266_bib58","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-123-2-199507150-00002","article-title":"Famciclovir for the treatment of acute herpes zoster: ef fects on acute disease and postherpetic neuralgia; a randomized, double-blind, placebo-controlled trial","volume":"123","author":"Tyring","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.12.1266_bib59","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM199807093390201","article-title":"A one year trial of lamivudine for chronic hepatitis B","volume":"339","author":"Lai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1266_bib60","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/hep.510280241","article-title":"Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B im mune globulin","volume":"28","author":"Markowtitz","year":"1998","journal-title":"Hepatology"},{"key":"10.4065\/74.12.1266_bib61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00003495-199652020-00006","article-title":"Cidofovir","volume":"52","author":"Lea","year":"1996","journal-title":"Drugs"},{"key":"10.4065\/74.12.1266_bib62","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-126-4-199702150-00001","article-title":"Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS: a randomized, controlled trial","volume":"126","author":"Lalezari","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.12.1266_bib63","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-126-4-199702150-00002","article-title":"Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC Peripheral Cytomegalovirus Retinitis Trial: a randomized, controlled trial","volume":"126","author":"Studies of Ocular Complications of AIDS Research Group In Collaboratlon With the AIDS Clinical Trials Group","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.12.1266_bib64","doi-asserted-by":"crossref","first-page":"98","DOI":"10.7326\/0003-4819-125-2-199607150-00003","article-title":"Treatment of cytomegalovirus retinitis with intra-vitreous cidofovir in patients with AIDS: a preliminary report","volume":"125","author":"Rahhal","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.12.1266_bib65","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/AAC.24.3.353","article-title":"Broad-spectrum antiviral activity of 2-(Vi>ribofurano-sylselenazole-4-carboxamide, a new antiviral agent","volume":"24","author":"Kirsi","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4065\/74.12.1266_bib66","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1001\/jama.1985.03360210063030","article-title":"Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease","volume":"254","author":"Hall","year":"1985","journal-title":"JAMA"},{"key":"10.4065\/74.12.1266_bib67","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJM198306163082403","article-title":"Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection: a randomized double-blind study","volume":"308","author":"Hall","year":"1983","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1266_bib68","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJM199107043250105","article-title":"A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection","volume":"325","author":"Smith","year":"1991","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1266_bib69","first-page":"566","article-title":"Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial","volume":"22","author":"Meert","year":"1994","journal-title":"CritCareMed"},{"key":"10.4065\/74.12.1266_bib70","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0022-3476(96)70294-9","article-title":"Effectiveness of ribavinn in otherwise well infants with respiratory syncytial virus-associated respiratory failure","volume":"128","author":"Moler","year":"1996","journal-title":"J Pediav"},{"key":"10.4065\/74.12.1266_bib71","series-title":"1997 Red Book: Report of the Committee on Infectious Diseases","first-page":"444","author":"American Academy ol Pediatrics","year":"1997"},{"key":"10.4065\/74.12.1266_bib72","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.1989.03420130042015","article-title":"The exposure of health care workers to ribavirin aerosol [letter]","volume":"261","author":"Guglielmo","year":"1989","journal-title":"JAMA"},{"key":"10.4065\/74.12.1266_bib73","first-page":"560","article-title":"Assessing exposures of health-care personnel to aerosols of ribavirin-California","volume":"37","author":"Centers for Disease Control","year":"1988","journal-title":"MMWR Morb Mortal WklyRep"},{"key":"10.4065\/74.12.1266_bib74","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/AAC.34.4.668","article-title":"Exposure of health care workers to ribavirin during therapy for respiratory syncytial virus infections","volume":"34","author":"Bradley","year":"1990","journal-title":"Antimicrob Agents Chemotfter"},{"key":"10.4065\/74.12.1266_bib75","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM199811193392102","article-title":"Inter feron alfa-2b alone or in combination with ribavinn for the treatment of relapse of chronic hepatitis C","volume":"339","author":"Davis","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1266_bib76","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"In-terferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C","volume":"339","author":"McHutchison","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1266_bib77","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1056\/NEJM199010183231607","article-title":"Lassa fever in the United States; investigation of a case and new guidelines for management","volume":"323","author":"Holmes","year":"1990","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1266_bib78","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0166-3542(87)90017-9","article-title":"Tolerance and antiviral effect of ribavirin in patients with Argentine hemorrhagic fever","volume":"7","author":"Enrla","year":"1987","journal-title":"Antiviral Res"},{"key":"10.4065\/74.12.1266_bib79","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00003495-199652010-00002","article-title":"New antiherpesvirus agents: their targets and therapeutic potential","volume":"52","author":"Alrablah","year":"1996","journal-title":"Drugs"},{"key":"10.4065\/74.12.1266_bib80","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archopht.1996.01100130021004","article-title":"Combination foscamet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS: the Cytomegalovirus Retreatiment Trial","volume":"114","author":"Studies of Ocular Complications of AIDS Research Group In Colliberation With the AIDS Clinical Trials Group","year":"1996","journal-title":"Arch Ophlrtalrnol"},{"key":"10.4065\/74.12.1266_bib81","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM198902023200506","article-title":"Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome","volume":"320","author":"Erlich","year":"1989","journal-title":"N Engl J Med"},{"issue":"RR-6","key":"10.4065\/74.12.1266_bib82","first-page":"l","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (AClP)","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.4065\/74.12.1266_bib83","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJM198209023071002","article-title":"A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection","volume":"307","author":"Dolin","year":"1982","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1266_bib84","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2165\/00003495-199855050-00015","article-title":"Zanamivir","volume":"55","author":"Waghom","year":"1998","journal-title":"Drugs"},{"key":"10.4065\/74.12.1266_bib85","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJM199709253371302","article-title":"Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections","volume":"337","author":"Hayden","year":"1997","journal-title":"N Engl j Med"},{"key":"10.4065\/74.12.1266_bib86","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(98)10190-3","article-title":"Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections [published errata appear in Lancet 1999; 353: 504 and 1999; 353:1104]","volume":"352","author":"MIST (Management of Influenza In the Southern Hemisphere Trialists) Study Group","year":"1998","journal-title":"Lancet"},{"key":"10.4065\/74.12.1266_bib87","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1001\/jama.282.1.31","article-title":"Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial","volume":"282","author":"Monto","year":"1999","journal-title":"JAMA"},{"key":"10.4065\/74.12.1266_bib88","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2165\/00003495-199856040-00003","article-title":"New approaches to influenza chemotherapy: neuraminidase inhibitors","volume":"56","author":"Catfee","year":"1998","journal-title":"Drugs"},{"key":"10.4065\/74.12.1266_bib89","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.282.13.1240","article-title":"Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment","volume":"282","author":"Hayden","year":"1999","journal-title":"JAMA"},{"key":"10.4065\/74.12.1266_bib90","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1056\/NEJM198610233151704","article-title":"Interferon therapy for condylomata acuminata","volume":"315","author":"Eron","year":"1986","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1266_bib91","doi-asserted-by":"crossref","first-page":"675","DOI":"10.7326\/0003-4819-108-5-675","article-title":"Treatment of condylorna acuminatum with three different interferons administered intralesionally: a double-blind, placebo-control led trial","volume":"108","author":"Reichman","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.12.1266_bib92","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1001\/jama.1991.03460200064036","article-title":"Recurrent condylomata acuminata treated with recombinant interferon alfa-2a: a multicenter double-blind placebo-controlled clinical trial","volume":"265","author":"Condylomata International Collaborative Study Group","year":"1991","journal-title":"JAMA"},{"key":"10.4065\/74.12.1266_bib93","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJM199605303342202","article-title":"Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B","volume":"334","author":"Nlederau","year":"1996","journal-title":"N Engl J Med"},{"key":"10.4065\/74.12.1266_bib94","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1086\/515626","article-title":"Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients","volume":"178","author":"Gaudreau","year":"1998","journal-title":"J Infect Dis"},{"key":"10.4065\/74.12.1266_bib95","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7326\/0003-4819-112-3-187","article-title":"Acyclovir resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS)","volume":"112","author":"Jacobson","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.12.1266_bib96","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1128\/CMR.12.2.286","article-title":"Resistance of human cytomegalovirus to antiviral drugs","volume":"12","author":"Erice","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.4065\/74.12.1266_bib97","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1086\/516446","article-title":"Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients","volume":"175","author":"Erice","year":"1997","journal-title":"J infect Dis"},{"key":"10.4065\/74.12.1266_bib98","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/infdis\/159.3.430","article-title":"Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance","volume":"159","author":"Belshe","year":"1989","journal-title":"J Infect Dis"},{"key":"10.4065\/74.12.1266_bib99","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1086\/516358","article-title":"Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immune-compromised adults","volume":"26","author":"Englund","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.12.1266_bib100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-3-642-77011-1_8","article-title":"Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine","volume":"176","author":"Hayden","year":"1992","journal-title":"CurrTop Microbiol Immunol"},{"key":"10.4065\/74.12.1266_bib101","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/314758","article-title":"Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants","volume":"179","author":"Groarke","year":"1999","journal-title":"J Infect Dis"},{"key":"10.4065\/74.12.1266_bib102","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1128\/CMR.10.4.674","article-title":"In search of a selective antiviral chemotherapy","volume":"10","author":"De Ciercq","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.4065\/74.12.1266_bib103","first-page":"760","article-title":"The immunosuppressive agent mycophen-oiate mofetil markedly potentiates the activity of lobucavir 11R(1a,2p,3ct)f-9-[2,3-bis(hydroxymethyl[cyclobutyl]guanine against different herpes viruses","volume":"67","author":"Neyts","year":"1999","journal-title":"Transpt\u00e0niaf\u00edor)"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961164161X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961164161X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T18:58:08Z","timestamp":1684868288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561961164161X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":103,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["S002561961164161X"],"URL":"https:\/\/doi.org\/10.4065\/74.12.1266","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}